Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INTERLEUKIN GENETICS INC | 20,120,724 | reported | 29 Jul 2016 | tx 2+40,241,448 |
| Mersana Therapeutics, Inc. | 5,959,520 | reported | 14 Sept 2020 | tx 2−6,000,000 |
| Enliven Therapeutics, Inc. | 3,305,601 | reported | 25 Jan 2022 | tx 3−134,558 |
| Mirna Therapeutics, Inc. | 1,499,166 | reported | 06 Oct 2015 | tx 7+2,971,517−1,825,209 |
| Surface Oncology, Inc. | 0 | reported | 23 Apr 2018 | tx 3+3,312,877−6,995,000 |
| APPIAN CORP | 0 | reported | 13 Feb 2018 | tx 6+5,544,718−11,089,436 |
| Tracon Pharmaceuticals, Inc. | 0 | reported | 04 Feb 2015 | tx 3+1,888,474−5,373,396 |
| MULESOFT, INC | 0 | reported | 01 May 2018 | tx 10+37,719,130−50,399,100 |
| Loxo Oncology, Inc. | 0 | reported | 06 Aug 2014 | tx 3+1,789,420−1,558,651 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Jan 2022 | SALE | Enliven Therapeutics, Inc. | 102,952 | 1.47 USD | |
| 21 Jan 2022 | SALE | Enliven Therapeutics, Inc. | 11,622 | 1.67 USD | |
| 24 Jan 2022 | SALE | Enliven Therapeutics, Inc. | 19,984 | 1.55 USD | |
| 14 Sept 2020 | OTHER | Mersana Therapeutics, Inc. | 2,000,000 | 0.00 USD | |
| 09 Apr 2020 | OTHER | Mersana Therapeutics, Inc. | 4,000,000 | 0.00 USD | |
| 01 May 2018 | TENDER | MULESOFT, INC | 12,679,970 | — | |
| 01 May 2018 | CONVERSION | MULESOFT, INC | 12,679,970 | — | |
| 01 May 2018 | CONVERSION | MULESOFT, INC | 12,679,970 | — | deriv |
| 23 Apr 2018 | CONVERSION | Surface Oncology, Inc. | 3,179,544 | — | |
| 23 Apr 2018 | PURCHASE | Surface Oncology, Inc. | 133,333 | 15.00 USD | first after silence |
| 23 Apr 2018 | CONVERSION | Surface Oncology, Inc. | 6,995,000 | — | deriv |
| 13 Feb 2018 | CONVERSION | APPIAN CORP | 2,724,202 | — | |
| 13 Feb 2018 | OTHER | APPIAN CORP | 2,724,202 | 0.00 USD | |
| 13 Feb 2018 | CONVERSION | APPIAN CORP | 2,724,202 | 0.00 USD | deriv |
| 20 Nov 2017 | SALE | APPIAN CORP | 2,820,516 | 19.49 USD | |
| 20 Nov 2017 | CONVERSION | APPIAN CORP | 2,820,516 | — | |
| 20 Nov 2017 | CONVERSION | APPIAN CORP | 2,820,516 | 0.00 USD | deriv |
| 22 Mar 2017 | OTHER | MULESOFT, INC | 12,679,970 | — | |
| 22 Mar 2017 | CONVERSION | MULESOFT, INC | 12,359,190 | — | |
| 22 Mar 2017 | CONVERSION | MULESOFT, INC | 1,689,436 | 0.00 USD | deriv |
| 22 Mar 2017 | CONVERSION | MULESOFT, INC | 8,000,038 | 0.00 USD | deriv |
| 22 Mar 2017 | OTHER | MULESOFT, INC | 12,679,970 | 0.00 USD | deriv |
| 22 Mar 2017 | CONVERSION | MULESOFT, INC | 605,668 | 0.00 USD | deriv |
| 22 Mar 2017 | CONVERSION | MULESOFT, INC | 2,064,048 | 0.00 USD | deriv |
| 29 Jul 2016 | PURCHASE | INTERLEUKIN GENETICS INC | 20,120,724 | 0.10 USD |
2 purchases reported after at least 12 months of silence — most recent on 23 Apr 2018.